Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Optic Neuropathy Global Clinical Trials Review, H1, 2015

Optic Neuropathy Global Clinical Trials Review, H1, 2015


  Request for Sample Report

Executive Summary

Optic Neuropathy Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Optic Neuropathy Global Clinical Trials Review, H1, 2015" provides data on the Optic Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Optic Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Optic Neuropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Optic Neuropathy 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Optic Neuropathy to Ophthalmology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Optic Neuropathy to Ophthalmology Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Top Companies Participating in Optic Neuropathy Therapeutics Clinical Trials 26

Prominent Drugs 27

Clinical Trial Profiles 28

Clinical Trial Overview of Top Companies 28

Sigma-Tau S.p.A. 28

Clinical Trial Overview of Sigma-Tau S.p.A. 28

SBI Biotech Co., Ltd. 29

Clinical Trial Overview of SBI Biotech Co., Ltd. 29

Regenera Pharma Ltd. 30

Clinical Trial Overview of Regenera Pharma Ltd. 30

Highmark Inc. 31

Clinical Trial Overview of Highmark Inc. 31

Eli Lilly and Company 32

Clinical Trial Overview of Eli Lilly and Company 32

Bayer AG 33

Clinical Trial Overview of Bayer AG 33

Allergan, Inc. 34

Clinical Trial Overview of Allergan, Inc. 34

Clinical Trial Overview of Top Institutes / Government 35

Tehran University of Medical Sciences 35

Clinical Trial Overview of Tehran University of Medical Sciences 35

Shahid Beheshti University of Medical Sciences 36

Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 36

Hong Kong Eye Hospital 37

Clinical Trial Overview of Hong Kong Eye Hospital 37

Second Military Medical University 38

Clinical Trial Overview of Second Military Medical University 38

Jikei University School of Medicine 39

Clinical Trial Overview of Jikei University School of Medicine 39

Isfahan University of Medical Sciences 40

Clinical Trial Overview of Isfahan University of Medical Sciences 40

Mount Sinai Hospital 41

Clinical Trial Overview of Mount Sinai Hospital 41

University of Colorado 42

Clinical Trial Overview of University of Colorado 42

University Hospital Tubingen 43

Clinical Trial Overview of University Hospital Tubingen 43

National Eye Institute 44

Clinical Trial Overview of National Eye Institute 44

Five Key Clinical Profiles 45

Appendix 64

Abbreviations 64

Definitions 64

Research Methodology 65

Secondary Research 65

About GlobalData 66

Contact Us 66

Disclaimer 66

Source 66

List of Figures

Optic Neuropathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Optic Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Optic Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Optic Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Optic Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Optic Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14

Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17

Optic Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Optic Neuropathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19

Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20

Optic Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Optic Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Optic Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23

Optic Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24

Optic Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Optic Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Optic Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

GlobalData Methodology 65

List of Tables

Optic Neuropathy Therapeutics, Global, Clinical Trials by Region, 2015* 7

Optic Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Optic Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Optic Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Optic Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Optic Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14

Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17

Optic Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Optic Neuropathy Therapeutics, Global, Clinical Trials by Phase, 2015* 19

Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20

Optic Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Optic Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Optic Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23

Optic Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24

Optic Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Optic Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Optic Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2015* 28

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by SBI Biotech Co., Ltd., 2015* 29

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Regenera Pharma Ltd., 2015* 30

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Highmark Inc., 2015* 31

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 32

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 33

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 34

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 35

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 36

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2015* 37

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Military Medical University, 2015* 38

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Jikei University School of Medicine, 2015* 39

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 40

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2015* 41

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 42

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2015* 43

Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Optic Neuropathy Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Optic Neuropathy, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com